Literature DB >> 22084515

Estimated global incidence of Japanese encephalitis: a systematic review.

Grant L Campbell1, Susan L Hills, Marc Fischer, Julie A Jacobson, Charles H Hoke, Joachim M Hombach, Anthony A Marfin, Tom Solomon, Theodore F Tsai, Vivien D Tsu, Amy S Ginsburg.   

Abstract

OBJECTIVE: To update the estimated global incidence of Japanese encephalitis (JE) using recent data for the purpose of guiding prevention and control efforts.
METHODS: Thirty-two areas endemic for JE in 24 Asian and Western Pacific countries were sorted into 10 incidence groups on the basis of published data and expert opinion. Population-based surveillance studies using laboratory-confirmed cases were sought for each incidence group by a computerized search of the scientific literature. When no eligible studies existed for a particular incidence group, incidence data were extrapolated from related groups.
FINDINGS: A total of 12 eligible studies representing 7 of 10 incidence groups in 24 JE-endemic countries were identified. Approximately 67,900 JE cases typically occur annually (overall incidence: 1.8 per 100,000), of which only about 10% are reported to the World Health Organization. Approximately 33,900 (50%) of these cases occur in China (excluding Taiwan) and approximately 51,000 (75%) occur in children aged 0-14 years (incidence: 5.4 per 100,000). Approximately 55,000 (81%) cases occur in areas with well established or developing JE vaccination programmes, while approximately 12,900 (19%) occur in areas with minimal or no JE vaccination programmes.
CONCLUSION: Recent data allowed us to refine the estimate of the global incidence of JE, which remains substantial despite improvements in vaccination coverage. More and better incidence studies in selected countries, particularly China and India, are needed to further refine these estimates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22084515      PMCID: PMC3209971          DOI: 10.2471/BLT.10.085233

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  35 in total

1.  Confirmation of Japanese encephalitis as an endemic human disease through sentinel surveillance in Indonesia.

Authors:  Sahat Ompusunggu; Susan L Hills; Masri Sembiring Maha; Vanda A Moniaga; Ni Ketut Susilarini; Anton Widjaya; Agus Sasmito; Agus Suwandono; Endang R Sedyaningsih; Julie A Jacobson
Journal:  Am J Trop Med Hyg       Date:  2008-12       Impact factor: 2.345

2.  Laboratory-based Japanese encephalitis surveillance in Nepal and the implications for a national immunization strategy.

Authors:  Thomas F Wierzba; Prakash Ghimire; Sarala Malla; Manas Kumar Banerjee; Sanjaya Shrestha; Basudha Khanal; Tika R Sedai; Robert V Gibbons
Journal:  Am J Trop Med Hyg       Date:  2008-06       Impact factor: 2.345

3.  Outcome and extent of disability following Japanese encephalitis in Indonesian children.

Authors:  Masri Sembiring Maha; Vanda A Moniaga; Susan L Hills; Anton Widjaya; Agus Sasmito; Renny Hariati; Yosef Kupertino; I Ketut Artastra; M Zaenal Arifin; Bambang Supraptono; Iskandar Syarif; Julie A Jacobson; Endang R Sedyaningsih
Journal:  Int J Infect Dis       Date:  2009-04-05       Impact factor: 3.623

Review 4.  Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

Authors:  Katherine L O'Brien; Lara J Wolfson; James P Watt; Emily Henkle; Maria Deloria-Knoll; Natalie McCall; Ellen Lee; Kim Mulholland; Orin S Levine; Thomas Cherian
Journal:  Lancet       Date:  2009-09-12       Impact factor: 79.321

Review 5.  Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.

Authors:  James P Watt; Lara J Wolfson; Katherine L O'Brien; Emily Henkle; Maria Deloria-Knoll; Natalie McCall; Ellen Lee; Orin S Levine; Rana Hajjeh; Kim Mulholland; Thomas Cherian
Journal:  Lancet       Date:  2009-09-12       Impact factor: 79.321

6.  Epidemiology and burden of disease from Japanese encephalitis in Cambodia: results from two years of sentinel surveillance.

Authors:  Sok Touch; Susan Hills; Buth Sokhal; Chham Samnang; Ly Sovann; Virak Khieu; Sann Chan Soeung; Kohei Toda; Jaimie Robinson; John Grundy
Journal:  Trop Med Int Health       Date:  2009-09-11       Impact factor: 2.622

7.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

8.  Japanese encephalitis in hill and mountain districts, Nepal.

Authors:  Anuj Bhattachan; Sumi Amatya; Tika Ram Sedai; Shyam Raj Upreti; Jeffrey Partridge
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

9.  Past, present, and future of Japanese encephalitis.

Authors:  Tobias E Erlanger; Svenja Weiss; Jennifer Keiser; Jürg Utzinger; Karin Wiedenmayer
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

10.  The epidemiology, clinical features, and long-term prognosis of Japanese encephalitis in central sarawak, malaysia, 1997-2005.

Authors:  Mong How Ooi; Penny Lewthwaite; Boon Foo Lai; Anand Mohan; Daniela Clear; Lina Lim; Shekhar Krishnan; Teresa Preston; Chae Hee Chieng; Phaik Hooi Tio; See Chang Wong; Jane Cardosa; Tom Solomon
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

View more
  305 in total

1.  Expression of domain III of the envelope protein from GP-78: a Japanese encephalitis virus.

Authors:  Sahil Kulkarni; Sandeepan Mukherjee; Krishna Mohan Padmanabha Das; Kaushiki Prabhudesai; Nupur Deshpande; Sushant Karnik; Abhay S Chowdhary; Usha Padmanabhan
Journal:  Virusdisease       Date:  2017-05-25

Review 2.  The role of chemokines in the pathogenesis of neurotropic flaviviruses.

Authors:  Susana V Bardina; Jean K Lim
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

3.  Investigation of the genotype III to genotype I shift in Japanese encephalitis virus and the impact on human cases.

Authors:  Na Han; James Adams; Wei Fang; Si-Qing Liu; Simon Rayner
Journal:  Virol Sin       Date:  2015-08-18       Impact factor: 4.327

4.  JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.

Authors:  Maximilian Larena; Natalie A Prow; Roy A Hall; Nikolai Petrovsky; Mario Lobigs
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

5.  Anticipating Emerging Mosquito-borne Flaviviruses in the USA: What Comes after Zika?

Authors:  Michelle V Evans; Courtney C Murdock; John M Drake
Journal:  Trends Parasitol       Date:  2018-03-15

6.  Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.

Authors:  Fang Li; Yueyun Wang; Lan Yu; Shengbo Cao; Ke Wang; Jiaolong Yuan; Chong Wang; Kunlun Wang; Min Cui; Zhen F Fu
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

7.  Structure-based mutational analysis of several sites in the E protein: implications for understanding the entry mechanism of Japanese encephalitis virus.

Authors:  Haibin Liu; Yi Liu; Shaobo Wang; Yanjun Zhang; Xiangyang Zu; Zheng Zhou; Bo Zhang; Gengfu Xiao
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

8.  Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012.

Authors:  Ingrid B Rabe; Elaine R Miller; Marc Fischer; Susan L Hills
Journal:  Vaccine       Date:  2014-12-09       Impact factor: 3.641

9.  Neurological sequelae of hospitalized Japanese encephalitis cases in Gansu province, China.

Authors:  Zundong Yin; Xuxia Wang; Li Li; Hui Li; Xiaoshu Zhang; Junhong Li; Guijun Ning; Fengqin Li; Xuefeng Liang; Li Gao; Xiaofeng Liang; Yixing Li
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

10.  Degradation of MicroRNA miR-466d-3p by Japanese Encephalitis Virus NS3 Facilitates Viral Replication and Interleukin-1β Expression.

Authors:  Hui Jiang; Lige Bai; Lina Ji; Zhuofang Bai; Jianwei Su; Tian Qin; Guojun Wang; Vinod Balasubramaniam; Xiao Wang; Min Cui; Jing Ye; Shengbo Cao; Guangpeng Li; Yang Yang
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.